JP2023522730A5 - - Google Patents
Info
- Publication number
- JP2023522730A5 JP2023522730A5 JP2022564073A JP2022564073A JP2023522730A5 JP 2023522730 A5 JP2023522730 A5 JP 2023522730A5 JP 2022564073 A JP2022564073 A JP 2022564073A JP 2022564073 A JP2022564073 A JP 2022564073A JP 2023522730 A5 JP2023522730 A5 JP 2023522730A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- variable region
- chain variable
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024218813A JP2025038088A (ja) | 2020-04-22 | 2024-12-13 | 抗cd73/抗pd-1二重特異性抗体及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010324783 | 2020-04-22 | ||
| CN202010324783.4 | 2020-04-22 | ||
| CN202110270671.X | 2021-03-12 | ||
| CN202110270671 | 2021-03-12 | ||
| PCT/CN2021/089059 WO2021213475A1 (zh) | 2020-04-22 | 2021-04-22 | 抗cd73-抗pd-1双特异性抗体及其用途 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218813A Division JP2025038088A (ja) | 2020-04-22 | 2024-12-13 | 抗cd73/抗pd-1二重特異性抗体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522730A JP2023522730A (ja) | 2023-05-31 |
| JP2023522730A5 true JP2023522730A5 (cg-RX-API-DMAC7.html) | 2023-07-10 |
| JP7763780B2 JP7763780B2 (ja) | 2025-11-04 |
Family
ID=78094648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564073A Active JP7763780B2 (ja) | 2020-04-22 | 2021-04-22 | 抗cd73/抗pd-1二重特異性抗体及びその使用 |
| JP2024218813A Pending JP2025038088A (ja) | 2020-04-22 | 2024-12-13 | 抗cd73/抗pd-1二重特異性抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218813A Pending JP2025038088A (ja) | 2020-04-22 | 2024-12-13 | 抗cd73/抗pd-1二重特異性抗体及びその使用 |
Country Status (13)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022002028A2 (pt) * | 2019-08-02 | 2022-04-12 | Cttq Akeso Shanghai Biomed Tech Co Ltd | Anticorpo anti-pd-1 e uso farmacêutico do mesmo |
| JP2023546743A (ja) * | 2020-10-23 | 2023-11-07 | 中山康方生物医▲藥▼有限公司 | 抗cd73抗体及びその使用 |
| CN118530342A (zh) * | 2021-03-12 | 2024-08-23 | 中山康方生物医药有限公司 | 降低免疫细胞分泌il-8和/或il-6的水平的方法 |
| IL286430A (en) * | 2021-09-14 | 2023-04-01 | Yeda Res & Dev | Multispecific antibodies for use in the treatment of diseases |
| AU2023252914A1 (en) | 2022-04-13 | 2024-10-17 | Arcus Biosciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
| EP4321537A4 (en) * | 2022-06-22 | 2025-04-23 | Akeso Biopharma, Inc. | Pharmaceutical composition and use thereof |
| CN116813786B (zh) * | 2023-08-03 | 2024-11-26 | 贝达药业股份有限公司 | 抗cd73抗体及其应用 |
| US20250230168A1 (en) | 2023-12-22 | 2025-07-17 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US9163087B2 (en) * | 2010-06-18 | 2015-10-20 | The Brigham And Women's Hospital, Inc. | Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions |
| RS62003B2 (sr) * | 2014-11-10 | 2025-01-31 | Medimmune Ltd | Vezujući molekuli specifični za cd73 i njihove upotrebe |
| EP3789403A1 (en) | 2014-11-11 | 2021-03-10 | MedImmune Limited | Therapeutic combinations comprising anti-cd73 antibodies and a2a receptor inhibitor and uses thereof |
| JP6805142B2 (ja) * | 2014-11-21 | 2020-12-23 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Cd73に対する抗体およびその使用 |
| JP7725185B2 (ja) * | 2015-10-06 | 2025-08-19 | アレクトル エルエルシー | 抗trem2抗体及びその使用方法 |
| IL290457B2 (en) * | 2015-12-30 | 2025-02-01 | Kodiak Sciences Inc | Antibodies and their conjugates |
| AU2017228470A1 (en) * | 2016-03-04 | 2018-08-30 | Bristol-Myers Squibb Company | Combination therapy with anti-CD73 antibodies |
| CN116271014A (zh) * | 2016-08-05 | 2023-06-23 | 中外制药株式会社 | 用于预防或治疗il-8相关疾病的组合物 |
| CN106977602B (zh) | 2016-08-23 | 2018-09-25 | 中山康方生物医药有限公司 | 一种抗pd1单克隆抗体、其药物组合物及其用途 |
| CN106967172B (zh) | 2016-08-23 | 2019-01-08 | 康方药业有限公司 | 抗ctla4-抗pd-1 双功能抗体、其药物组合物及其用途 |
| CA3080976A1 (en) * | 2017-11-06 | 2019-05-09 | Corvus Pharmaceuticals, Inc. | Adenosine pathway inhibitors for cancer treatment |
| AU2019231172B2 (en) * | 2018-03-09 | 2023-08-24 | Phanes Therapeutics, Inc. | Anti-CD73 antibodies and uses thereof |
| CA3096674A1 (en) * | 2018-04-12 | 2019-10-17 | Bristol-Myers Squibb Company | Anticancer combination therapy with cd73 antagonist antibody and pd-1/pd-l1 axis antagonist antibody |
| CN112041348B (zh) | 2018-07-25 | 2023-09-22 | 天境生物科技(上海)有限公司 | 抗cd73抗pd-l1双特异性抗体 |
| CN109053895B (zh) | 2018-08-30 | 2020-06-09 | 中山康方生物医药有限公司 | 抗pd-1-抗vegfa的双功能抗体、其药物组合物及其用途 |
| WO2021213466A1 (zh) | 2020-04-22 | 2021-10-28 | 中山康方生物医药有限公司 | 抗cd73的抗体及其用途 |
-
2021
- 2021-04-22 BR BR112022021426A patent/BR112022021426A2/pt unknown
- 2021-04-22 CN CN202110440285.0A patent/CN113527501B/zh active Active
- 2021-04-22 AU AU2021261803A patent/AU2021261803B2/en active Active
- 2021-04-22 JP JP2022564073A patent/JP7763780B2/ja active Active
- 2021-04-22 US US17/996,878 patent/US20230151111A1/en active Pending
- 2021-04-22 KR KR1020227040580A patent/KR20230004726A/ko not_active Ceased
- 2021-04-22 IL IL297432A patent/IL297432A/en unknown
- 2021-04-22 WO PCT/CN2021/089059 patent/WO2021213475A1/zh not_active Ceased
- 2021-04-22 EP EP21792313.5A patent/EP4141033A4/en active Pending
- 2021-04-22 PH PH1/2022/552785A patent/PH12022552785A1/en unknown
- 2021-04-22 CA CA3176321A patent/CA3176321A1/en active Pending
- 2021-04-22 MX MX2022013311A patent/MX2022013311A/es unknown
-
2022
- 2022-10-18 ZA ZA2022/11405A patent/ZA202211405B/en unknown
-
2024
- 2024-12-13 JP JP2024218813A patent/JP2025038088A/ja active Pending
-
2026
- 2026-06-05 AU AU2026204349A patent/AU2026204349A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11845795B2 (en) | NKp46 binding proteins | |
| US11202828B2 (en) | Therapeutic SIRP-α antibodies | |
| RU2767357C2 (ru) | Биспецифические антитела-ингибиторы контрольных точек | |
| EP3405492B1 (en) | Multispecific molecules targeting cll-1 | |
| JP2022542450A5 (cg-RX-API-DMAC7.html) | ||
| CN115175702A (zh) | 用于体内生物靶向的材料和方法 | |
| AU2019356806B2 (en) | Antibody constructs binding 4-1BB and tumor-associated antigens and uses thereof | |
| CA2936785A1 (en) | Bi-specific cd3 and cd19 antigen-binding constructs | |
| CA2903056A1 (en) | Tetravalent bispecific antibodies | |
| US20230279108A1 (en) | Therapeutic sirp-alpha antibodies | |
| CN115175938A (zh) | 制导和导航控制(gnc)抗体样蛋白及其制备和使用方法 | |
| JP2025038088A (ja) | 抗cd73/抗pd-1二重特異性抗体及びその使用 | |
| JP2024515396A5 (cg-RX-API-DMAC7.html) | ||
| US20250270315A1 (en) | Novel anti-sirpa antibodies | |
| JP2024540148A5 (cg-RX-API-DMAC7.html) | ||
| AU2022332499A1 (en) | Fap/cd40 binding molecule and medicinal use thereof | |
| US20230265202A1 (en) | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof | |
| CA3255392A1 (en) | Anti-Dectin-1 Antibodies and Their Methods of Use | |
| AU2021224787A1 (en) | CD137 binding molecules and uses thereof | |
| WO2018237364A1 (en) | Asymmetric heterodimeric fc-scfv fusion anti-globo h and anti-cd3 bispecifc antibody and uses thereof in caner therapy | |
| RU2024107310A (ru) | Радиоконъюгаты к psma и способы их применения | |
| HK40073540A (zh) | 制导和导航控制(gnc)抗体样蛋白及其制备和使用方法 |